NDC 10019-145-01 - Propranolol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10019-145
- Requested NDC
- 10019-145-01
- Package NDCs from labels
- 10019-145-43, 10019-145-01
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2008-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propranolol Hydrochloride - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2008-01-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10019-145-01 | Propranolol Hydrochloride | 10 in 1 BOX | INJECTION | 10 | 2 | |
| 10019-145-43 | Propranolol Hydrochloride | 1 mL in 1 AMPULE | INJECTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| propranolol hydrochloride | ACTIVE INGREDIENT | F8A3652H1V | PROPRANOLOL HYDROCHLORIDE (PROPRANOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 2 | |
| Propranolol | ACTIVE MOIETY | 9Y8NXQ24VQ | PROPRANOLOL HYDROCHLORIDE (PROPRANOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 2 | |
| citric acid | INACTIVE INGREDIENT | 2968PHW8QP | PROPRANOLOL HYDROCHLORIDE (PROPRANOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | PROPRANOLOL HYDROCHLORIDE (PROPRANOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PROPRANOLOL | PROPRANOLOL HYDROCHLORIDE | Henry Schein, Inc. | e586996d-9035-4ef4-8c8d-06e70a02577f | 2026-11-06 | Warnings, Adverse reactions | 856443 |
| PROPRANOLOL | PROPRANOLOL | HF Acquisition Co LLC, DBA HealthFirst | 54dd0fad-64ee-788f-e063-6394a90ac88e | 2026-06-22 | Warnings, Adverse reactions | 856443 |
| Propranolol Hydrochloride | PROPRANOLOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 91f2ff1d-68d8-4e83-a2db-618f0410ead7 | 2026-01-12 | Warnings, Adverse reactions | 856443 |
| Propranolol | PROPRANOLOL HYDROCHLORIDE | ProPharma Distribution | 45b0aaf0-df6c-7db0-e063-6294a90a9135 | 2025-12-11 | Warnings, Adverse reactions | 856443 |
| Propranolol Hydrochloride | PROPRANOLOL HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 693569bd-6053-5b3e-e053-2a91aa0a6e9c | 2023-05-23 | Warnings, Adverse reactions | 856443 |
| Propranolol | PROPRANOLOL HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 9e50d1ee-b7f3-e549-e053-2995a90a4a86 | 2023-05-09 | Warnings, Adverse reactions | 856443 |
| Propranolol | PROPRANOLOL HYDROCHLORIDE | Fresenius Kabi USA, LLC | f14ea537-dd5c-4c78-9037-9a85e9e610ef | 2023-01-12 | Warnings, Adverse reactions | 856443 |
| 91D1AAD4-301D-D02C-2322-573F2D7BB015 | 1f0f5fb3-5292-4d04-b590-3c90a663eec8 | 2008-01-24 | Warnings, Adverse reactions | 91D1AAD4-301D-D02C-2322-573F2D7BB015 1f0f5fb3-5292-4d04-b590-3c90a663eec8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.